Company: CSTL
Filing Date: 2025-03-28
Form Type: PRE 14A
Source: 0001447362-25-000050
Chunk: 19

Company: CASTLE BIOSCIENCES INC
Filing Date: 2025-03-28
Form: PRE 14A
Chunk 19
---
 Daniel M. Bradbury     |     |       |     |                 |     |                                     |
| Rodney Cotton          |     |     M |     |               M |     |                                     |
| Total meetings in 2024 |     |     4 |     |               3 |     |                                   4 |
| Committee Independence |     |  100% |     |            100% |     |                                100% |
| Financial Expertise    |     |  100% |     |             75% |     |                                 75% |

#### C

#### = Committee Chair

#### M

#### = Committee Member
(1) Effective as of the closing of the Annual Meeting, Ms. Goldberg will replace Mr. Harrison as chair of the Compensation Committee.

Each of the committees has authority to engage legal counsel or other experts or consultants, as it deems appropriate to carry out its responsibilities. The board of directors has affirmatively determined that each member of each committee satisfies the applicable independence requirements of the SEC and Nasdaq and is free of any relationship that would impair his or her individual exercise of independent judgment with regard to the Company. Below is a description of each committee of the board of directors.

#### Audit Committee
Our Audit Committee consists of G. Bradley Cole , Kimberlee S. Caple, Rodney Cotton, and Tiffany P. Olson . Our board of directors has determined that each member of our Audit Committee satisfies the applicable SEC and Nasdaq independence requirements. The board of directors evaluates the independence of Audit Committee members on an annual basis and has determined that all members of our Audit Committee satisfy the independence criteria set forth in Rule 10A-3(b)(1) promulgated under the Exchange Act and Nasdaq Listing Rule 5605(c)(2)(A)(i) and (ii). Mr. Cole serves as the Chair of our Audit Committee. The Audit Committee met four times during the last fiscal year. The board of directors has adopted a written Audit Committee Charter that is available to stockholders on the Company’s website at www.CastleBiosciences.com on the “Investors” page under “Corporate Governance.” The functions of this committee include, among other things:

#### Castle Biosciences 2025 Proxy Statement23
| Information Regarding the Board of Directors and Corporate Governance |

• evaluating the performance, independence and qualifications of our independent auditors and determining whether to retain our existing independent auditors or engage new independent auditors;

• reviewing and approving the engagement of our independent auditors